Zota Health Care Limited – Investor Presentation Summary

Key Operational Highlights

  • Davaindia retail pharmacy chain reached 2,840 active stores as of 30th September 2026 (1,859 COCO stores, 981 FOFO stores)
  • Quarterly customer footfalls of 66.17 lakh in Q2FY27
  • Davaindia Gross Merchandise Value (GMV) of ₹18,791 lakhs for Q2FY27
  • Portfolio includes 2,000+ SKUs in Davaindia and 4,000+ products in domestic marketing business
  • 80% repeat customer rate for Davaindia, with ~60% of revenue from chronic disease category
  • Export operations serve 30+ countries with 325 product approvals received out of 586 dossiers applications
  • Key drivers: Rapid store expansion, hyperlocal e-commerce model, private-label products, and elimination of traditional supply chain

Segment-wise Performance

  • Davaindia: Revenue of ₹16,846.81 lakhs in Q2FY27 (65.18% gross margin)
  • Domestic Marketing: Revenue of ₹2,459.13 lakhs in Q2FY27 (27.05% gross margin)
  • Exports: Revenue of ₹470.09 lakhs in Q2FY27 (61.81% gross margin)
  • Everyday Herbal Group: Revenue of ₹806.79 lakhs in Q2FY27 (31.34% gross margin)
  • Significant changes: Davaindia sales grew 76.25% YoY, Everyday Herbal Group grew 78.99% YoY

Financial Highlights

Revenue: ₹19,933.14 lakhs (Q2FY27)

EBITDA: ₹791.72 lakhs (Q2FY27)

PAT: ₹-2,596.01 lakhs (Q2FY27)

EPS: Not Specified

Margins: Gross margin 60.17%, EBITDA margin 3.97%

YoY/QoQ comparison: Revenue grew 54.58% YoY; EBITDA turned positive from -₹955.40 lakhs in Q1FY27

Drivers of financial performance: Strong Davaindia sales growth, operational efficiency improvements

Comparison to market estimates: Not Specified

Key Risks: Not explicitly disclosed

Geographical Revenue Split

Domestic vs Export/Regional Revenue:

  • Domestic operations: Primary focus with 1,050+ distributors across India
  • Export operations: 30+ countries served, mainly CIS, Latin America, Africa, and Asia
  • Regional Breakdown: Not Specified

Balance Sheet Snapshot

Net Debt/Equity: Not Specified

Reserves: Other Equity of ₹59,096.52 lakhs (as of 30th September 2026)

Current Assets/Liabilities: Current Assets ₹50,624.92 lakhs, Current Liabilities ₹27,340.76 lakhs

Working Capital/Leverage Metrics: Not Specified

Financial Health Insights: Cash and cash equivalents of ₹862.04 lakhs; Total borrowings of ₹3,203.53 lakhs (current and non-current)

Capex & Cash Flow Health

Capital Expenditure: Not Specified for current period

Free Cash Flow: Not Specified

Operating Cash Flow: Not Specified

Net Debt Movement: Not Specified

Investment Rationale: Focus on retail expansion, backward integration through acquisitions

Strategic & R&D Initiatives

Investments in Innovation: Hyperlocal B2C online portal and mobile app; cloud-based software & AI for store operations and supply chain

Expected impact on growth: Enhanced customer experience and operational efficiency

Strategic Rationale: Expanding retail footprint, strengthening supply chain through acquisitions (87.78% stake in Everyday Herbal Group)

Industry Trends & Business Environment

Macro/Industry Trends: Growing demand for affordable generic medicines

Impact on Company: Davaindia's value proposition of 30-90% savings on medicines positions it well in the market

Management Commentary & Growth Outlook

Strategic Outlook: Focus on sustainable and disciplined growth; intention to accelerate Davaindia network additions during H2FY27

FY Guidance: Progress towards full-year expansion plans while maintaining focus on store-level productivity and operating efficiency

Market Share Targets: Not Specified

Risks and Opportunities: Not Specified